Firstly, some data suggest that NAFLD may be the source of pro-inflammatory factors, including fetuin-A, plasminogen activator inhibitor-1 (PAI-1) and human fibroblast growth factor-21 (FGF-21), which may cause kidney damage [17], [18], [19]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.